Induction of Multi-Functional T Cells in a Phase I Clinical Trial of Dendritic Cell Immunotherapy in Hepatitis C Virus Infected Individuals

We have previously reported a world-first phase I clinical trial to treat HCV patients using monocyte-derived dendritic cells (Mo-DC) loaded with HCV-specific lipopeptides. While the brief treatment proved to be safe, it failed to reduce the viral load and induced only transient cell-mediated immune...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shuo, Roberts, Stuart, Plebanski, Magdalena, Gouillou, Maelenn, Spelman, Tim, Latour, Philippe, Jackson, David, Brown, Lorena, Sparrow, Rosemary L., Prince, H. Miles, Hart, Derek, Loveland, Bruce E., Gowans, Eric J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419178/
https://www.ncbi.nlm.nih.gov/pubmed/22905088
http://dx.doi.org/10.1371/journal.pone.0039368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419178/
https://www.ncbi.nlm.nih.gov/pubmed/22905088
http://dx.doi.org/10.1371/journal.pone.0039368

Ejemplares similares